Purpose: Baduanjin exercise's effect on blood pressure, lipid profile, and cognitive function in subclinical hypothyroidism (SCH) women with mild cognitive impairment (MCI) was the aim investigated in forty elderly with mild SCH and MCI.

Methods: Women who administered 12-week levothyroxine medication were randomly assigned to a control group (n=20 SCH women) or Baduanjin-exercise group. Assessment of triglycerides (TG), body mass index (BMI), blood pressure, Addenbrooke's Cognitive Examination III Questionnaire (ACEQ-III), low-density and high-density lipoproteins (LD-lipo, HD-lipo), and cholesterol (CH) was conducted.

Results: All variables improved significantly in both groups. The Baduanjin group's improvements were higher than the control group's improvements. A trend of significant improvements (P<0.05) in all variables was achieved toward the group of Baduanjin exercise during the post-value comparison of all variables between SCH groups.

Conclusion: Adding Baduanjin to pharmacotherapies of SCH not only improves blood pressure, TSH, lipids, and BMI, but also improves MCI in older women.